CD82 and melanoma: To investigate the therapeutic potential of KAI1 against tumor growth, we first examined the anti-angiogenic role of rhKAI1 using three-dimensional hybrid spheres consisting of cancer and blood vessel cells (melanoma cells; B16 (mouse melanoma cancer cells), ECs; MS1, and PCs; 10T1/2).